Diabetes Mellitus is a persistent and perpetual metabolism disorder. It is characterized by high blood glucose level that results in the inability to produce and/or use insulin.
ß cells in a healthy pancreas produce and release insulin, which controls glucose levels in the blood. The number of ß cells is maintained by constant apoptosis and proliferation. However in diabetic patients the delicate balance in number is lost. Therefore protection of the remaining cells and adding a sufficient number of ß cells is the focus of cell therapy of diabetes.
Diabetes awareness is vital, since uncontrolled Diabetes may lead to devastating complications such as cardiovascular diseases, blindness, kidney failure, nerve damage, diabetic foot.
Currently lots of conventional therapies are available for diabetes such as insulin injection and oral hypoglycemic drugs. Many treatments can relieve or delay the onset and development of diabetes and related complications. Yet they do not address the root of the problem that causes pancreatic ß cell dysfunction.
The objective of stem cell treatment for Diabetes is to protect the remaining cells and replenish sufficent ß cells. The treatment enables patients to reduce their insulin and hypoglycemic medications, in some cases even stop taking them. Also relieves chronic diabetic complications.
100% of 27 Diabetes patients gained improvements between the period of April to November 2010. 92.6% of patients improved within the first month after treatment, which enabled them to gradually reduce insulin and medications. 7.4% of patients started to improve within 3 months after discharge.
Achieved results are seen as follows:
- 9% of patients could decrease their insulin injections & hypoglycemic medications by more than 50%
- 7% of Type 1 and 11.1% of Type 2 patients could completely stop insulin injections
- improved pancreatic islet function
- stable blood glucose level throughout the day
- improved symptoms of diabetes associated complications such as diabetic retinopathy, diabetic nephropathy, diabetic macrovascular pathological changes, diabetic peripheral neuropathy and diabetic autonomic neuropathy.